摘要
癌症和老化是两种相似的代表许多不可逆功能减退的时间相关累积的最后结果的进程,主要由压力诱导DNA和细胞损伤所造成。细胞凋亡和衰老是细胞对待癌症和老化的两种回应,即使通过不同的机制。致癌作用与细胞引发凋亡和衰老能力显著降低有关。相反的是,在老化的组织中,衰老细胞的累积会增加,细胞凋亡反常种类的天性依赖于组织。因此,普遍的模型认为细胞凋亡和衰老功能是两种潜在的肿瘤抑制机制,确保个体在早期和复制阶段的健康,但是在晚年时不利于人体并促进老化。不同的抗癌媒介,包括规范诱导的细胞凋亡,也诱导了细胞衰老,这一发现证明了促衰老战略可能应用于癌症防治治疗。因此,机制媒介在细胞凋亡和衰老间微妙平衡的详细研究将对治疗开发同时拥有抗癌和抗老化特征的战略有利,包括最小化这些战略的副作用。在此,我们综述了关于细胞凋亡和衰老在癌症和老化中的作用。
关键词: 老化,细胞凋亡,癌症,细胞衰老,压力,治疗。
图形摘要
Current Drug Targets
Title:Roles of Apoptosis and Cellular Senescence in Cancer and Aging
Volume: 17 Issue: 4
Author(s): Claudia Cerella, Cindy Grandjenette, Mario Dicato and Marc Diederich
Affiliation:
关键词: 老化,细胞凋亡,癌症,细胞衰老,压力,治疗。
摘要: Cancer and aging are two similar processes representing the final outcome of timedependent accumulation of various irreversible dysfunctions, mainly caused by stress-induced DNA and cellular damages. Apoptosis and senescence are two types of cellular response to damages that are altered in both cancer and aging, albeit through different mechanisms. Carcinogenesis is associated with a progressive reduction in the ability of the cells to trigger apoptosis and senescence. In contrast, in aging tissues, there is an increased accumulation of senescent cells, and the nature of apoptosis deregulation varies depending on the tissue. Thus, the prevailing model suggests that apoptosis and cellular senescence function as two essential tumor-suppressor mechanisms, ensuring the health of the individual during early and reproductive stages of life, but become detrimental and promote aging later in life. The recent discovery that various anticancer agents, including canonical inducers of apoptosis, act also as inducers of cellular senescence indicates that pro-senescence strategies may have applications in cancer prevention therapy. Therefore, dissection of the mechanisms mediating the delicate balance between apoptosis and cellular senescence will be beneficial in the therapeutic exploitation of both processes in the development of future anticancer and anti-aging strategies, including minimizing the side effects of such strategies. Here, we provide an overview of the roles of apoptosis and cellular senescence in cancer and aging.
Export Options
About this article
Cite this article as:
Claudia Cerella, Cindy Grandjenette, Mario Dicato and Marc Diederich , Roles of Apoptosis and Cellular Senescence in Cancer and Aging, Current Drug Targets 2016; 17 (4) . https://dx.doi.org/10.2174/1389450116666150202155915
DOI https://dx.doi.org/10.2174/1389450116666150202155915 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Immunophilins in Nervous System Degeneration and Regeneration
Current Topics in Medicinal Chemistry Recent Patents on Cell Cycle Regulatory Proteins
Recent Patents on Biotechnology Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Classification of Sarcomas Using Bioinformatics and Molecular Profiling
Current Pharmaceutical Biotechnology Fungal Proteins with Antiproliferative and Anticancer Activities
Protein & Peptide Letters Synthetic Src-Kinase Domain Inhibitors and Their Structural Requirements
Anti-Cancer Agents in Medicinal Chemistry Anticancer Therapeutic Strategies Based on CDK Inhibitors
Current Pharmaceutical Design New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Current Cancer Drug Targets New Insights Into the Molecular Mechanisms of Action of Bisphosphonates
Current Pharmaceutical Design Manipulating the Ability of Substituted Titanocene Derivatives to Induce Apoptosis in Castrate-Resistant Prostate Cancer Cells
Letters in Drug Design & Discovery Cyclin-Dependent Kinase as a Novel Therapeutic Target: An Endless Story
Current Chemical Biology Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells
Current Cancer Therapy Reviews Structure-Function Relationships of PEDF
Current Molecular Medicine Protein Kinase CK2 in Human Diseases
Current Medicinal Chemistry Cell Penetrating Peptides for Tumor Targeting
Current Pharmaceutical Biotechnology Gene Delivery for Cancer Therapy
Current Drug Delivery Spinophilin: A New Tumor Suppressor at 17q21
Current Molecular Medicine Caspase-Independent Pathways of Programmed Cell Death: The Unraveling of New Targets of Cancer Therapy?
Current Cancer Drug Targets Deubiquitinating Enzymes: Their Functions and Substrate Specificity
Current Protein & Peptide Science Stem Cells as Vectors to Deliver HSV/tk Gene Therapy for Malignant Gliomas
Current Stem Cell Research & Therapy